APA (7th ed.) Citation

Ruwaard, J., L' Ami, M., Kneepkens, E., Krieckaert, C., Nurmohamed, M., Hooijberg, F., . . . Wolbink, G. (2023). Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A randomized controlled trial. Scandinavian Journal of Rheumatology, 52(2), 129. https://doi.org/10.1080/03009742.2022.2028364

Chicago Style (17th ed.) Citation

Ruwaard, J., et al. "Interval Prolongation of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: A Randomized Controlled Trial." Scandinavian Journal of Rheumatology 52, no. 2 (2023): 129. https://doi.org/10.1080/03009742.2022.2028364.

MLA (9th ed.) Citation

Ruwaard, J., et al. "Interval Prolongation of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: A Randomized Controlled Trial." Scandinavian Journal of Rheumatology, vol. 52, no. 2, 2023, p. 129, https://doi.org/10.1080/03009742.2022.2028364.